Alli
Alli bottles tampered with in US, drug recalled
March 27, 2014Manufacturing and Production, Sales and Marketing Alli, FDA, GSK, Roche, Xenical, obesity, weight loss
GlaxoSmithKline has admitted that some bottles of its weight-loss drug Alli bought in the US have been tampered with. US …
GlaxoSmithKline to drop Alli and other OTC products
April 15, 2011Research and Development, Sales and Marketing Alli, GSK, OTC, Tyverb
GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …
Takeda obesity drug falters at phase II
March 18, 2011Research and Development Alli, Amylin, Contrave, Meridia, Qnexa, Takeda, Xenical, lorcaserin, metreleptin, obesity, pramlintide
Yet another investigational drug appears to have faltered on the rocky path to develop anti-obesity treatments. Takeda Pharmaceutical Company and …
EMA under fire for blocking data access
June 8, 2010Research and Development, Sales and Marketing Acomplia, Alli, EMA, Xenical, data
The European ombudsman has called for the European Medicines Agency to grant access to clinical study reports and trial protocols …
GSK plans obesity documentary
January 29, 2010Medical Communications Alli, GSK, obesity
Obesity is about to get the Hollywood treatment with GlaxoSmithKline Consumer Healthcare funding a documentary by Oscar-winning director Barry Levinson. …
GSK launches Alli in Europe
April 22, 2009Sales and Marketing Alli, Europe, GSK
GSK has launched Alli, making it the first clinically proven over-the-counter weight loss aid to be available in pharmacies across …
